Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Glucosylceramidase market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Glucosylceramidasemarket, defines the market attractiveness level of Glucosylceramidase market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Glucosylceramidase industry, describes the types of Glucosylceramidase market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glucosylceramidase market and the development prospects and opportunities of Glucosylceramidase industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glucosylceramidase market in Chapter 13.
By Player:
greenovation Biotech GmbH
Shire Plc
JCR Pharmaceuticals Co, Ltd
Bioorganic Research and Services SA
Pharming Group NV
The International Biotechnology Center (IBC) Generium
Amicus Therapeutics, Inc
Protalix BioTherapeutics, Inc
By Type:
AVRRD-02
LTI-291
NCGC-607
Pcgin
Others
By End-User:
Genetic Disorders
Gaucher Disease
Parkinson's Disease
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Glucosylceramidase Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Glucosylceramidase Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Glucosylceramidase Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Glucosylceramidase Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Glucosylceramidase Market Analysis and Outlook to 2022
-
7.1 Global Glucosylceramidase Consumption (2017-2022)
-
7.2 United States Glucosylceramidase Consumption (2017-2022)
-
7.3 Europe Glucosylceramidase Consumption (2017-2022)
-
7.4 China Glucosylceramidase Consumption (2017-2022)
-
7.5 Japan Glucosylceramidase Consumption (2017-2022)
-
7.6 India Glucosylceramidase Consumption (2017-2022)
-
7.7 South Korea Glucosylceramidase Consumption (2017-2022)
8 Region and Country-wise Glucosylceramidase Market Analysis and Outlook to 2028
-
8.1 Global Glucosylceramidase Consumption Forecast (2022-2028)
-
8.2 United States Glucosylceramidase Consumption Forecast (2022-2028)
-
8.3 Europe Glucosylceramidase Consumption Forecast (2022-2028)
-
8.4 China Glucosylceramidase Consumption Forecast (2022-2028)
-
8.5 Japan Glucosylceramidase Consumption Forecast (2022-2028)
-
8.6 India Glucosylceramidase Consumption Forecast (2022-2028)
-
8.7 South Korea Glucosylceramidase Consumption Forecast (2022-2028)
9 Global Glucosylceramidase Market Outlook by Types and Applications to 2022
-
9.1 Global Glucosylceramidase Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AVRRD-02 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global LTI-291 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global NCGC-607 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Pcgin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Glucosylceramidase Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Genetic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Gaucher Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Glucosylceramidase Market Outlook by Types and Applications to 2028
-
10.1 Global Glucosylceramidase Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AVRRD-02 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global LTI-291 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global NCGC-607 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Pcgin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Glucosylceramidase Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Gaucher Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Glucosylceramidase Import and Export Analysis (Top 5 Countries)
-
11.1 Global Glucosylceramidase Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Glucosylceramidase Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Glucosylceramidase Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Glucosylceramidase Market Competitive Analysis
-
14.1 greenovation Biotech GmbH
-
14.1.1 greenovation Biotech GmbH Company Details
-
14.1.2 greenovation Biotech GmbH Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 greenovation Biotech GmbH Glucosylceramidase Product and Service
-
14.2 Shire Plc
-
14.2.1 Shire Plc Company Details
-
14.2.2 Shire Plc Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Shire Plc Glucosylceramidase Product and Service
-
14.3 JCR Pharmaceuticals Co, Ltd
-
14.3.1 JCR Pharmaceuticals Co, Ltd Company Details
-
14.3.2 JCR Pharmaceuticals Co, Ltd Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 JCR Pharmaceuticals Co, Ltd Glucosylceramidase Product and Service
-
14.4 Bioorganic Research and Services SA
-
14.4.1 Bioorganic Research and Services SA Company Details
-
14.4.2 Bioorganic Research and Services SA Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bioorganic Research and Services SA Glucosylceramidase Product and Service
-
14.5 Pharming Group NV
-
14.5.1 Pharming Group NV Company Details
-
14.5.2 Pharming Group NV Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pharming Group NV Glucosylceramidase Product and Service
-
14.6 The International Biotechnology Center (IBC) Generium
-
14.6.1 The International Biotechnology Center (IBC) Generium Company Details
-
14.6.2 The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 The International Biotechnology Center (IBC) Generium Glucosylceramidase Product and Service
-
14.7 Amicus Therapeutics, Inc
-
14.7.1 Amicus Therapeutics, Inc Company Details
-
14.7.2 Amicus Therapeutics, Inc Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Amicus Therapeutics, Inc Glucosylceramidase Product and Service
-
14.8 Protalix BioTherapeutics, Inc
-
14.8.1 Protalix BioTherapeutics, Inc Company Details
-
14.8.2 Protalix BioTherapeutics, Inc Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Protalix BioTherapeutics, Inc Glucosylceramidase Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Glucosylceramidase
-
Figure Glucosylceramidase Picture
-
Table Global Glucosylceramidase Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glucosylceramidase Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glucosylceramidase Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Glucosylceramidase Consumption by Country (2017-2022)
-
Figure United States Glucosylceramidase Consumption and Growth Rate (2017-2022)
-
Table Europe Glucosylceramidase Consumption and Growth Rate (2017-2022)
-
Figure China Glucosylceramidase Consumption and Growth Rate (2017-2022)
-
Figure Japan Glucosylceramidase Consumption and Growth Rate (2017-2022)
-
Figure India Glucosylceramidase Consumption and Growth Rate (2017-2022)
-
Figure South Korea Glucosylceramidase Consumption and Growth Rate (2017-2022)
-
Figure Global Glucosylceramidase Consumption Forecast by Country (2022-2028)
-
Figure United States Glucosylceramidase Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Glucosylceramidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Glucosylceramidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Glucosylceramidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Glucosylceramidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Glucosylceramidase Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AVRRD-02 Consumption and Growth Rate (2017-2022)
-
Figure Global LTI-291 Consumption and Growth Rate (2017-2022)
-
Figure Global NCGC-607 Consumption and Growth Rate (2017-2022)
-
Figure Global Pcgin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Gaucher Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AVRRD-02 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LTI-291 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global NCGC-607 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pcgin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gaucher Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parkinson's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Glucosylceramidase Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Glucosylceramidase Export by Region (Top 5 Countries) (2017-2028)
-
Table greenovation Biotech GmbH (Foundation Year, Company Profile and etc.)
-
Table greenovation Biotech GmbH Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table greenovation Biotech GmbH Glucosylceramidase Product and Service
-
Table Shire Plc (Foundation Year, Company Profile and etc.)
-
Table Shire Plc Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Plc Glucosylceramidase Product and Service
-
Table JCR Pharmaceuticals Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table JCR Pharmaceuticals Co, Ltd Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table JCR Pharmaceuticals Co, Ltd Glucosylceramidase Product and Service
-
Table Bioorganic Research and Services SA (Foundation Year, Company Profile and etc.)
-
Table Bioorganic Research and Services SA Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bioorganic Research and Services SA Glucosylceramidase Product and Service
-
Table Pharming Group NV (Foundation Year, Company Profile and etc.)
-
Table Pharming Group NV Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group NV Glucosylceramidase Product and Service
-
Table The International Biotechnology Center (IBC) Generium (Foundation Year, Company Profile and etc.)
-
Table The International Biotechnology Center (IBC) Generium Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table The International Biotechnology Center (IBC) Generium Glucosylceramidase Product and Service
-
Table Amicus Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Amicus Therapeutics, Inc Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus Therapeutics, Inc Glucosylceramidase Product and Service
-
Table Protalix BioTherapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Protalix BioTherapeutics, Inc Glucosylceramidase Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protalix BioTherapeutics, Inc Glucosylceramidase Product and Service
-
